SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for 18F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation

By afschroeder • September 19, 2025

Packard RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, Coelho M, Dorbala S, Galt J, Hyun M, Menon N, Miller EJ, Shetty M, Saraste A. SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for ¹⁸F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation. J Nucl Med. 2025 Sep 18:jnumed.125.270873. doi: 10.2967/jnumed.125.270873. Epub ahead of print. PMID: 40967753.

Tags: 18F-flurpiridaz, Cardiology/Epi, myocardial blood flow, myocardial perfusion imaging, Positron emission tomography, practice guideline, Publications

Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [177Lu]Lu-PSMA-617: A Single-Center Retrospective Study

Murthy V, Kimura K, Theus L, Nguyen A, Grogan TR, Lokre O, Perk T, Rettig MB, Drakaki A, Shen J, Thin P, Nguyen K, Lira[...]

New strategies for valve replacement and interventional options in adults with congenital heart disease: new insights from Euro-ACHD 2025

Butera G, Chessa M, Gaio G, Kempny A, Uebing A, Michielon G, Aboulhosn J, Giamberti A, Hoschtitzky A, d'Udekem Y. New strategies for valve replacement[...]

Navigating the Complexities of Carcinoid Heart Disease and Severe Coronary Artery Disease: A Case for Multidisciplinary Collaboration

Arbit B. Navigating the Complexities of Carcinoid Heart Disease and Severe Coronary Artery Disease: A Case for Multidisciplinary Collaboration. Cureus. 2025 Dec 23;17(12):e99940. doi: 10.7759/cureus.99940.[...]